<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39551951</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1949-0984</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Gut microbes</Title><ISOAbbreviation>Gut Microbes</ISOAbbreviation></Journal><ArticleTitle>Dysrupted microbial tryptophan metabolism associates with SARS-CoV-2 acute inflammatory responses and long COVID.</ArticleTitle><Pagination><StartPage>2429754</StartPage><MedlinePgn>2429754</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2429754</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/19490976.2024.2429754</ELocationID><Abstract><AbstractText>Protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and risk of long COVID has been associated with the depletion or over-abundance of specific taxa within the gut microbiome. However, the microbial mechanisms mediating these effects are not yet known. We hypothesized that altered microbial production of tryptophan and its downstream derivatives might contribute to inappropriate immune responses to viral infection. In patients hospitalized with COVID-19 (<i>n</i>&#x2009;=&#x2009;172), serum levels of tryptophan and indole-3-propionate (IPA) negatively correlated with serum levels of many proinflammatory mediators (including C-reactive protein and Serum amyloid A), while C-glycosyltryptophan (C-Trp), indole-3-lactic acid (ILA) and indole-3-acetic acid (IAA) levels were positively correlated with levels of acute phase proteins, proinflammatory cytokines, alarmins and chemokines. A similar pattern was observed in long COVID patients (<i>n</i>&#x2009;=&#x2009;20) where tryptophan and IPA were negatively associated with a large number of serum cytokines, while C-Trp and IAA were positively associated with circulating cytokine levels. Metagenomic analysis of the fecal microbiota showed the relative abundance of genes encoding the microbial enzymes required for tryptophan production (e.g. anthranilate synthase) and microbial tryptophan metabolism was significantly lower in patients hospitalized with COVID-19 (<i>n</i>&#x2009;=&#x2009;380) compared to healthy controls (<i>n</i>&#x2009;=&#x2009;270). Microbial tryptophan metabolites reduced innate cell proinflammatory responses to cytosolic DNA sensor Stimulator of interferon genes (STING), toll-like receptor (TLR)-3 and TLR-4 stimulation <i>in vitro</i>, while IL-10&#xa0;secretion was enhanced. Microbial tryptophan metabolites also modified <i>ex vivo</i> human lymphocyte responses by limiting the production of TH1 and TH17 associated cytokines, while enhancing secretion of IL-22. These data suggest that lower levels of tryptophan production and tryptophan metabolism by gut microbes may increase the risk of severe and chronic outcomes to SARS-CoV-2 infection due to impaired innate and adaptive responses to infection. Screening patients for lower-level microbiome capacity for tryptophan metabolism may help identify at-risk individuals.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Microbiology, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APC Microbiome Ireland, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devotta</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Microbiology, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APC Microbiome Ireland, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Junhui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Microbiology, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APC Microbiome Ireland, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lunjani</LastName><ForeName>Nonhlanhla</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>APC Microbiome Ireland, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Dermatology, University Hospital Limerick, Limerick, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadlier</LastName><ForeName>Corinna</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Cork University Hospital, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavelle</LastName><ForeName>Aonghus</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4461-8596</Identifier><AffiliationInfo><Affiliation>APC Microbiome Ireland, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albrich</LastName><ForeName>Werner C</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases &amp; Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walter</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Microbiology, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APC Microbiome Ireland, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Toole</LastName><ForeName>Paul W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>School of Microbiology, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APC Microbiome Ireland, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Mahony</LastName><ForeName>Liam</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4705-3583</Identifier><AffiliationInfo><Affiliation>School of Microbiology, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APC Microbiome Ireland, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University College Cork, Cork, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gut Microbes</MedlineTA><NlmUniqueID>101495343</NlmUniqueID><ISSNLinking>1949-0976</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8DUH1N11BX</RegistryNumber><NameOfSubstance UI="D014364">Tryptophan</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007211">Indoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>830-96-6</RegistryNumber><NameOfSubstance UI="C015292">indolepropionic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007210">Indoleacetic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>6U1S09C61L</RegistryNumber><NameOfSubstance UI="C030737">indoleacetic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>5SW11R7M7M</RegistryNumber><NameOfSubstance UI="C024139">indole-3-lactic acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014364" MajorTopicYN="Y">Tryptophan</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="Y">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="Y">Feces</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007210" MajorTopicYN="N">Indoleacetic Acids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Microbiota</Keyword><Keyword MajorTopicYN="N">indoles</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">tryptophan</Keyword></KeywordList><CoiStatement>LOM is a consultant to PrecisionBiotics and has received research funding from GSK, Chiesi, Reckitt and Fonterra. LOM has participated in speaker&#x2019;s bureau for Nestle, Nutricia, Yakult, Reckitt and Abbott. PWOT has received funding from Fonterra New Zealand and has participated in a speaker&#x2019;s bureau for Yakult-Springer/Nature. None of the other authors report any potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>0</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>17</Day><Hour>23</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39551951</ArticleId><ArticleId IdType="doi">10.1080/19490976.2024.2429754</ArticleId><ArticleId IdType="pmc">PMC11581176</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diener C, Dai CL, Wilmanski T, Baloni P, Smith B, Rappaport N, Hood L, Magis AT, Gibbons SM.. Genome-microbiome interplay provides insight into the determinants of the human blood metabolome. Nat Metab. 2022. Nov;4(11):1560&#x2013;18. doi:10.1038/s42255-022-00670-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-022-00670-1</ArticleId><ArticleId IdType="pmc">PMC9691620</ArticleId><ArticleId IdType="pubmed">36357685</ArticleId></ArticleIdList></Reference><Reference><Citation>Losol P, Wolska M, Wypych TP, Yao L, O&#x2019;Mahony L, Sokolowska M. A cross talk between microbial metabolites and host immunity: its relevance for allergic diseases. Clin Transl Allergy. 2024. Feb;14(2):e12339. doi:10.1002/clt2.12339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clt2.12339</ArticleId><ArticleId IdType="pmc">PMC10859320</ArticleId><ArticleId IdType="pubmed">38342758</ArticleId></ArticleIdList></Reference><Reference><Citation>Forde B, Yao L, Shaha R, Murphy S, Lunjani N, O&#x2019;Mahony L. Immunomodulation by foods and microbes: unravelling the molecular tango. Allergy. 2022. Dec;77(12):3513&#x2013;3526. doi:10.1111/all.15455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15455</ArticleId><ArticleId IdType="pmc">PMC10087875</ArticleId><ArticleId IdType="pubmed">35892227</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy M, Thaiss CA, Zeevi D, Dohnalov&#xe1; L, Zilberman-Schapira G, Mahdi JA, David E, Savidor A, Korem T, Herzig Y, et al. Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell. 2015. Dec 3;163(6):1428&#x2013;1443. doi:10.1016/j.cell.2015.10.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.10.048</ArticleId><ArticleId IdType="pmc">PMC5665753</ArticleId><ArticleId IdType="pubmed">26638072</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcik W, Pugin B, Bresc&#xf3; MS, Westermann P, Rinaldi A, Groeger D, Van Elst D, Sokolowska M, Krawczyk K, Frei R, et al. Bacterial secretion of histamine within the gut influences immune responses within the lung. Allergy. 2019. May;74(5):899&#x2013;909. doi:10.1111/all.13709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13709</ArticleId><ArticleId IdType="pubmed">30589936</ArticleId></ArticleIdList></Reference><Reference><Citation>Wawrzyniak M, Groeger D, Frei R, Ferstl R, Wawrzyniak P, Krawczyk K, Pugin B, Barcik W, Westermann P, Dreher A, et al. Spermidine and spermine exert protective effects within the lung. Pharmacol Res Perspect. 2021. Aug;9(4):e00837. doi:10.1002/prp2.837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.837</ArticleId><ArticleId IdType="pmc">PMC8294051</ArticleId><ArticleId IdType="pubmed">34289267</ArticleId></ArticleIdList></Reference><Reference><Citation>Levan SR, Stamnes KA, Lin DL, Panzer AR, Fukui E, McCauley K, Fujimura KE, McKean M, Ownby DR, Zoratti EM, et al. Elevated faecal 12,13-diHOME concentration in neonates at high risk for asthma is produced by gut bacteria and impedes immune tolerance. Nat Microbiol. 2019. Nov;4(11):1851&#x2013;1861. doi:10.1038/s41564-019-0498-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0498-2</ArticleId><ArticleId IdType="pmc">PMC6830510</ArticleId><ArticleId IdType="pubmed">31332384</ArticleId></ArticleIdList></Reference><Reference><Citation>Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod LP, Harris NL, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20(2):159&#x2013;66. 45. doi:10.1038/nm.3444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3444</ArticleId><ArticleId IdType="pubmed">24390308</ArticleId></ArticleIdList></Reference><Reference><Citation>Antunes KH, Fachi JL, de Paula R, da Silva EF, Pral LP, dos Santos A&#xc1;, Dias GBM, Vargas JE, Puga R, Mayer FQ, et al. Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nat Commun. 2019. Jul 22;10(1):3273. doi:10.1038/s41467-019-11152-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11152-6</ArticleId><ArticleId IdType="pmc">PMC6646332</ArticleId><ArticleId IdType="pubmed">31332169</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng L, Kelly CJ, Battista KD, Schaefer R, Lanis JM, Alexeev EE, Wang RX, Onyiah JC, Kominsky DJ, Colgan SP, et al. Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor&#x2013;dependent repression of claudin-2. J Immunol. 2017;199(8):2976&#x2013;2984. 48. doi:10.4049/jimmunol.1700105.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1700105</ArticleId><ArticleId IdType="pmc">PMC5636678</ArticleId><ArticleId IdType="pubmed">28893958</ArticleId></ArticleIdList></Reference><Reference><Citation>Thio CL, Chi P-Y, Lai ACY, Chang Y-J. Regulation of type 2 innate lymphoid cell&#x2013;dependent airway hyperreactivity by butyrate. J Allergy Clin Immunol. 2018;142(6):1867&#x2013;1883.e12. doi:10.1016/j.jaci.2018.02.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.02.032</ArticleId><ArticleId IdType="pubmed">29522844</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki M, Suaini NHA, Afghani J, Heye KN, O&#x2019;Mahony L, Venter C, Lauener R, Frei R, Roduit C. Systematic review of the association between short chain fatty acids and allergic diseases. Allergy. 2024. Feb 23;79(7):1789&#x2013;1811. doi:10.1111/all.16065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.16065</ArticleId><ArticleId IdType="pubmed">38391245</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheorghe CE, Martin JA, Manriquez FV, Dinan TG, Cryan JF, Clarke G. Focus on the essentials: tryptophan metabolism and the microbiome-gut-brain axis. Curr Opin Pharmacol. 2019. Oct;48:137&#x2013;145. doi:10.1016/j.coph.2019.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2019.08.004</ArticleId><ArticleId IdType="pubmed">31610413</ArticleId></ArticleIdList></Reference><Reference><Citation>Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host &amp; Microbe. 2018. June 13;23(6):716&#x2013;724. doi:10.1016/j.chom.2018.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.05.003</ArticleId><ArticleId IdType="pubmed">29902437</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelante T, Puccetti M, Giovagnoli S, Romani L. Regulation of host physiology and immunity by microbial indole-3-aldehyde. Curr Opin Immunol. 2021. June;70:27&#x2013;32. doi:10.1016/j.coi.2020.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2020.12.004</ArticleId><ArticleId IdType="pubmed">33454521</ArticleId></ArticleIdList></Reference><Reference><Citation>Valler-Colmer M, Falony G, Darzi Y, Tigchelaar EF, Wang J, Tito RY, Schiweck C, Kurilshikov A, Joossens M, Wijmenga C, et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol. 2019;4(4):623&#x2013;632. doi:10.1038/s41564-018-0337-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0337-x</ArticleId><ArticleId IdType="pubmed">30718848</ArticleId></ArticleIdList></Reference><Reference><Citation>Schell MA, Karmirantzou M, Snel B, Vilanova D, Berger B, Pessi G, Zwahlen M-C, Desiere F, Bork P, Delley M, et al. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci USA. 2002;99(22):14422&#x2013;14427. doi:10.1073/pnas.212527599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.212527599</ArticleId><ArticleId IdType="pmc">PMC137899</ArticleId><ArticleId IdType="pubmed">12381787</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Chen S, Wu D, Wu J, Chen J. [Effect of mufti-gene knockout of L-tryptophan transport system on L-tryptophan production in Escherichia coli]. Sheng Wu Gong Cheng Xue Bao. 2011;27(12):1765&#x2013;1772.</Citation><ArticleIdList><ArticleId IdType="pubmed">22506417</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C, Li G, Zheng Q, Gu X, Shi Q, Su Y, Chu Q, Yuan X, Bao Z, Lu J, et al. Tryptophan metabolism in health and disease. Cell Metab. 2023. Aug 8;35(8):1304&#x2013;1326. doi:10.1016/j.cmet.2023.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2023.06.004</ArticleId><ArticleId IdType="pubmed">37352864</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, Zecchi R, D&#x2019;Angelo C, Massi-Benedetti C, Fallarino F, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39(2):372&#x2013;385. doi:10.1016/j.immuni.2013.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.08.003</ArticleId><ArticleId IdType="pubmed">23973224</ArticleId></ArticleIdList></Reference><Reference><Citation>Swimm A, Giver CR, DeFilipp Z, Rangaraju S, Sharma A, Ulezko Antonova A, Sonowal R, Capaldo C, Powell D, Qayed M, et al. Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease. Blood. 2018;132(23):2506&#x2013;2519. doi:10.1182/blood-2018-03-838193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-03-838193</ArticleId><ArticleId IdType="pmc">PMC6284212</ArticleId><ArticleId IdType="pubmed">30257880</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell DN, Swimm A, Sonowal R, Bretin A, Gewirtz AT, Jones RM, Kalman D. Indoles from the commensal microbiota act via the AHR and IL-10 to tune the cellular composition of the colonic epithelium during aging. Proc Natl Acad Sci USA. 2020;117(35):21519&#x2013;21526. doi:10.1073/pnas.2003004117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003004117</ArticleId><ArticleId IdType="pmc">PMC7474656</ArticleId><ArticleId IdType="pubmed">32817517</ArticleId></ArticleIdList></Reference><Reference><Citation>Donia MS, Cimermancic P, Schulze CJ, Wieland Brown LC, Martin J, Mitreva M, Clardy J, Linington RG, Fischbach MA. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell. 2014;158(6):1402&#x2013;1414. doi:10.1016/j.cell.2014.08.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.08.032</ArticleId><ArticleId IdType="pmc">PMC4164201</ArticleId><ArticleId IdType="pubmed">25215495</ArticleId></ArticleIdList></Reference><Reference><Citation>Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Br&#xfc;ggen MC, O&#x2019;Mahony L, Gao Y, Nadeau K, Akdis CA. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020. Jul;75(7):1564&#x2013;1581. doi:10.1111/all.14364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14364</ArticleId><ArticleId IdType="pmc">PMC7272948</ArticleId><ArticleId IdType="pubmed">32396996</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430&#x2013;436. doi:10.1038/s41586-020-2521-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022. Mar 11;375(6585):1122&#x2013;1127. doi:10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, Redfield S, Austin JP, Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021. Aug;38:101019. doi:10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahony L, Buwalda T, Blair M, Forde B, Lunjani N, Ambikan A, Neogi U, Barrett P, Geary E, O&#x2019; Connor N, et al. Impact of Long COVID on health and quality of life. HRBOpen Res. 2022. Apr;22(5): 31.</Citation></Reference><Reference><Citation>Untersmayr E, Venter C, Smith P, Rohrhofer J, Ndwandwe C, Schwarze J, Shannon E, Sokolowska M, Sadlier C, O&#x2019;Mahony L. Immune Mechanisms Underpinning Long COVID: Collegium Internationale Allergologicum Update 2024. Int Arch Allergy Immunol. 2024. Jan 22;185(5):489&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">38253027</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahearn-Ford S, Lunjani N, McSharry B, MacSharry J, Fanning L, Murphy G, Everard C, Barry A, McGreal A, Al Lawati SM, et al. Long-term disruption of cytokine signalling networks is evident in patients who required hospitalization for SARS-CoV-2 infection. Allergy. 2021. Sep;76(9):2910&#x2013;2913. doi:10.1111/all.14953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14953</ArticleId><ArticleId IdType="pmc">PMC8222932</ArticleId><ArticleId IdType="pubmed">34028045</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrich WC, Ghosh TS, Ahearn-Ford S, Mikaeloff F, Lunjani N, Forde B, Suh N, Kleger GR, Pietsch U, Frischknecht M, et al. A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2. Gut Microbes. 2022;14(1). doi:10.1080/19490976.2022.2073131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2022.2073131</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunjani N, Albrich WC, Suh N, Barda B, Finnegan LA, Dam SA, Walter J, Sadlier C, Horgan M, O&#x2019;Toole PW, et al. Higher levels of bacterial DNA in serum associate with severe and fatal COVID-19. Allergy. 2022. Jan 12;77(4):1312&#x2013;1314. doi:10.1111/all.15218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15218</ArticleId><ArticleId IdType="pmc">PMC9303653</ArticleId><ArticleId IdType="pubmed">35020222</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, Chung AC, Cheung CP, Tso EY, Fung KS, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698&#x2013;706. doi:10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung ACK, Cheung CP, Chen N, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944&#x2013;955.e8. doi:10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadlier C, Albrich WC, Neogi U, Lunjani N, Horgan M, O&#x2019;Toole PW, O&#x2019;Mahony L. Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19. Allergy. 2022. May;77(5):1623&#x2013;1625. doi:10.1111/all.15253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15253</ArticleId><ArticleId IdType="pmc">PMC9111264</ArticleId><ArticleId IdType="pubmed">35150456</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Ghosh TS, McCann R, Mallon P, Hill C, Draper L, Schult D, Fanning LJ, Shannon R, Sadlier C, et al. Robust cross-cohort gut microbiome associations with COVID-19 severity. Gut Microbes. 2023. Jan;15(1):2242615. doi:10.1080/19490976.2023.2242615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2023.2242615</ArticleId><ArticleId IdType="pmc">PMC10411309</ArticleId><ArticleId IdType="pubmed">37550964</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspi R, Billington R, Fulcher CA, Keseler IM, Kothari A, Krummenacker M, Latendresse M, Midford PE, Ong Q, Ong WK, et al. The MetaCyc database of metabolic pathways and enzymes. Nucleic Acids Res. 2018;46(D1):D633&#x2013;D639. doi:10.1093/nar/gkx935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx935</ArticleId><ArticleId IdType="pmc">PMC5753197</ArticleId><ArticleId IdType="pubmed">29059334</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla AF, Supasitthumrong T, Tunvirachaisakul C, Algon AAA, Al-Hakeim HK, Maes M. The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2022. Jul 15;22(1):615. doi:10.1186/s12879-022-07582-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07582-1</ArticleId><ArticleId IdType="pmc">PMC9284970</ArticleId><ArticleId IdType="pubmed">35840908</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AC, Devason AS, Umana IC, Cox TO, Dohnalov&#xe1; L, Litichevskiy L, Perla J, Lundgren P, Etwebi Z, Izzo LT, et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023. Oct 26;186(22):4851&#x2013;4867.e20. doi:10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagan T, Cortese M, Rouphael N, Boudreau C, Linde C, Maddur MS, Das J, Wang H, Guthmiller J, Zheng NY, et al. Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans. Cell. 2019. Sep;178(6):1313&#x2013;1328.e13. doi:10.1016/j.cell.2019.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.08.010</ArticleId><ArticleId IdType="pmc">PMC6750738</ArticleId><ArticleId IdType="pubmed">31491384</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Hernandez MM, Vital M, Mohney RP, Spector TD, Valdes AM. Circulating levels of the anti-oxidant indoleproprionic acid are associated with higher gut microbiome diversity. Gut Microbes. 2019;10(6):688&#x2013;695. doi:10.1080/19490976.2019.1586038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2019.1586038</ArticleId><ArticleId IdType="pmc">PMC6866703</ArticleId><ArticleId IdType="pubmed">31030641</ArticleId></ArticleIdList></Reference><Reference><Citation>Sehgal R, de Mello VD, M&#xe4;nnist&#xf6; V, Lindstr&#xf6;m J, Tuomilehto J, Pihlajam&#xe4;ki J, Uusitupa M. Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease. Nutrients. 2022;14(21):4695. doi:10.3390/nu14214695.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14214695</ArticleId><ArticleId IdType="pmc">PMC9653718</ArticleId><ArticleId IdType="pubmed">36364957</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Chen C, Gao J. Extensive Summary of the Important Roles of Indole Propionic Acid, a Gut Microbial Metabolite in Host Health and Disease. Nutrients. 2023;15(1):151. doi:10.3390/nu15010151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15010151</ArticleId></ArticleIdList></Reference><Reference><Citation>Heumel S, de Rezende Rodovalho V, Urien C, Specque F, Brito Rodrigues P, Robil C, Delval L, Sencio V, Descat A, Deruyter L, et al. Shotgun metagenomics and systemic targeted metabolomics highlight indole-3-propionic acid as a protective gut microbial metabolite against influenza infection. Gut Microbes. 2024;16(1):2325067. doi:10.1080/19490976.2024.2325067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2024.2325067</ArticleId><ArticleId IdType="pmc">PMC10936607</ArticleId><ArticleId IdType="pubmed">38445660</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh M, Mukherjee S, Wang H, Li H, Sun K, Benechet AP, Qiu Z, Maher L, Redinbo MR, Phillips RS, et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity. 2014;41(2):296&#x2013;310. doi:10.1016/j.immuni.2014.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.06.014</ArticleId><ArticleId IdType="pmc">PMC4142105</ArticleId><ArticleId IdType="pubmed">25065623</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi PY. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 2020. Oct 6;33(1):108234. doi:10.1016/j.celrep.2020.108234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108234</ArticleId><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung KI, McKenna S, Vijayamahantesh V, He Y, Hahm B. Protective versus Pathogenic Type I Interferon Responses during Virus Infections. Viruses. 2023. Sep 13;15(9):1916. doi:10.3390/v15091916.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15091916</ArticleId><ArticleId IdType="pmc">PMC10538102</ArticleId><ArticleId IdType="pubmed">37766322</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS, Sonnenburg JL. Diet-induced extinctions in the gut microbiota compound over generations. Nature. 2016. Jan 14;529(7585):212&#x2013;215. doi:10.1038/nature16504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature16504</ArticleId><ArticleId IdType="pmc">PMC4850918</ArticleId><ArticleId IdType="pubmed">26762459</ArticleId></ArticleIdList></Reference><Reference><Citation>Fragiadakis GK, Smits SA, Sonnenburg ED, Van Treuren W, Reid G, Knight R, Manjurano A, Changalucha J, Dominguez-Bello MG, Leach J, et al. Links between environment, diet, and the hunter-gatherer microbiome. Gut Microbes. 2019;10(2):216&#x2013;227. doi:10.1080/19490976.2018.1494103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2018.1494103</ArticleId><ArticleId IdType="pmc">PMC6546328</ArticleId><ArticleId IdType="pubmed">30118385</ArticleId></ArticleIdList></Reference><Reference><Citation>Korpela K, Hurley S, Ford SA, Franklin R, Byrne S, Lunjani N, Forde B, Neogi U, Venter C, Walter J, et al. Association between gut microbiota development and allergy in infants born during pandemic-related social distancing restrictions. Allergy. 2024. Jul;79(7):1938&#x2013;1951. doi:10.1111/all.16069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.16069</ArticleId><ArticleId IdType="pubmed">38419554</ArticleId></ArticleIdList></Reference><Reference><Citation>Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222&#x2013;227. doi:10.1038/nature11053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11053</ArticleId><ArticleId IdType="pmc">PMC3376388</ArticleId><ArticleId IdType="pubmed">22699611</ArticleId></ArticleIdList></Reference><Reference><Citation>Merino J, Joshi AD, Nguyen LH, Leeming ER, Mazidi M, Drew DA, Gibson R, Graham MS, Lo C-H, Capdevila J, et al. Diet quality and risk and severity of COVID-19: a prospective cohort study. Gut. 2021. Nov;70(11):2096&#x2013;2104. doi:10.1136/gutjnl-2021-325353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325353</ArticleId><ArticleId IdType="pmc">PMC8500931</ArticleId><ArticleId IdType="pubmed">34489306</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagielski P, &#x141;uszczki E, Wn&#x119;k D, Micek A, Boles&#x142;awska I, Pi&#xf3;recka B, Kawalec P. Associations of Nutritional Behavior and Gut Microbiota with the Risk of COVID-19 in Healthy Young Adults in Poland. Nutrients. 2022;14(2):350. doi:10.3390/nu14020350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14020350</ArticleId><ArticleId IdType="pmc">PMC8779092</ArticleId><ArticleId IdType="pubmed">35057534</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Rebholz CM, Hegde S, LaFiura C, Raghavan M, Lloyd JF, Cheng S, Seidelmann SB. Plant-based diets, pescatarian diets and COVID-19 severity: a population-based case&#x2013;control study in six countries. BMJ Nutr Prev Health. 2021;4(1):257&#x2013;266. doi:10.1136/bmjnph-2021-000272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjnph-2021-000272</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzin V, Galili G, Aharoni A. Shikimate Pathway and Aromatic Amino Acid Biosynthesis. In: eLS. Chichester: John Wiley &amp; Sons, Ltd; 2012. Aug. doi:10.1002/9780470015902.a0001315.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470015902.a0001315.pub2</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda H, Dudareva N. The shikimate pathway and aromatic amino Acid biosynthesis in plants. Annu Rev Plant Biol. 2012;63(1):73&#x2013;105. doi:10.1146/annurev-arplant-042811-105439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-arplant-042811-105439</ArticleId><ArticleId IdType="pubmed">22554242</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T, Wu J, Zeng Y, Li J, Yan J, Meng W, Han H, Feng F, He J, Zhao S, et al. SARS-CoV-2 triggered oxidative stress and abnormal energy metabolism in gut microbiota. MedComm. 2022. Jan 17;3(1):e112. doi:10.1002/mco2.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mco2.112</ArticleId><ArticleId IdType="pmc">PMC8906553</ArticleId><ArticleId IdType="pubmed">35281785</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, Song ZG, Liu C, Tan S, Lin S, Zhu J, Dai FH, Gao J, She JL, Mei Z, et al. Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients. BMC Med. 2022. Jan 20;20(1):24. doi:10.1186/s12916-021-02212-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02212-0</ArticleId><ArticleId IdType="pmc">PMC8769945</ArticleId><ArticleId IdType="pubmed">35045853</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Yang S, Zhou Y, Disoma C, Dong Z, Du A, Zhang Y, Chen Y, Huang W, Chen J, et al. Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota. Front Microbiol. 2021. Oct 11;12:712081. doi:10.3389/fmicb.2021.712081.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.712081</ArticleId><ArticleId IdType="pmc">PMC8542975</ArticleId><ArticleId IdType="pubmed">34707577</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC, Ng SSS, Zhang F, Li AYL, Lu W, Hui DS, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022. Mar;71(3):544&#x2013;552. doi:10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Wan Y, Zuo T, Yeoh YK, Liu Q, Zhang L, Zhan H, Lu W, Xu W, Lui GCY, et al. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19. Gastroenterology. 2022. Feb;162(2):548&#x2013;561.e4. doi:10.1053/j.gastro.2021.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.013</ArticleId><ArticleId IdType="pmc">PMC8529231</ArticleId><ArticleId IdType="pubmed">34687739</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton GJ, Chen-Liaw A, Cossarini F, Livanos AE, Spindler MP, Plitt T, Eggers J, Mogno I, Gonzalez-Reiche AS, Siu S, et al. Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. Sci Rep. 2021. June 25;11(1):13308. doi:10.1038/s41598-021-92740-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92740-9</ArticleId><ArticleId IdType="pmc">PMC8233421</ArticleId><ArticleId IdType="pubmed">34172783</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghini F, McIver LJ, Blanco-M&#xed;guez A, Dubois L, Asnicar F, Maharjan S, Mailyan A, Manghi P, Scholz M, Maltez Thomas A, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife. 2021;10:e65088. doi:10.7554/eLife.65088.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.65088</ArticleId><ArticleId IdType="pmc">PMC8096432</ArticleId><ArticleId IdType="pubmed">33944776</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H, Fran&#xe7;ois R, Henry L, M&#xfc;ller K, Vaughan D. dplyr: A Grammar of Data Manipulation. R package version 1.1.4. 2023. https://github.com/tidyverse/dplyr. https://dplyr.tidyverse.org.</Citation></Reference><Reference><Citation>Wickham H. ggplot2: Elegant Graphics for Data Analysis. (NY): Springer-Verlag; 2016. ISBN 978-3-319-24277-4. https://ggplot2.tidyverse.org.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>